Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)

Phase Distribution

Ph not_applicable
9
90%
Ph phase_3
1
10%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 3Large-scale testing
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(5)
Other(5)

Detailed Status

unknown5
Completed5

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (10.0%)
N/A9 (90.0%)

Trials by Status

unknown550%
completed550%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
OTHER
Total Trials
10